CompletedPhase 4NCT00726713

Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

Studying OBSOLETE: Acquired metabolic neuropathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pamlab, Inc.
Principal Investigator
Vivian Fonseca, MD
Tulane University Health Sciences Center
Intervention
Metanx (a medical food)(other)
Enrollment
214 enrolled
Eligibility
25-80 years · All sexes
Timeline
20082011

Study locations (6)

Collaborators

Tulane University Health Sciences Center · VA Nebraska Western Iowa Health Care System · Scott and White Hospital & Clinic · Dallas Diabetes and Endocrine Center · University of Alabama at Birmingham · dgd Research, Inc. · Baylor Health Care System

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00726713 on ClinicalTrials.gov

Other trials for OBSOLETE: Acquired metabolic neuropathy

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Acquired metabolic neuropathy

← Back to all trials